Snu114 is the only GTPase required for mRNA splicing. As a homolog of elongation factor G, it contains three domains (III-V) predicted to undergo a large rearrangement following GTP hydrolysis. To assess the functional importance of the domains of Snu114, we used random mutagenesis to create conditionally lethal alleles. We identified three main classes: (1) mutations that are predicted to affect GTP binding and hydrolysis, (2) mutations that are clustered in 10-to 20-amino-acid stretches in each of domains III-V, and (3) mutations that result in deletion of up to 70 amino acids from the C terminus. Representative mutations from each of these classes blocked the first step of splicing in vivo and in vitro. The growth defects caused by most alleles were synthetically exacerbated by mutations in PRP8, a U5 snRNP protein that physically interacts with Snu114, as well as in genes involved in snRNP biogenesis, including SAD1 and BRR1. The allele snu114-60, which truncates the C terminus, was synthetically lethal with factors required for activation of the spliceosome, including the DExD/H-box ATPases BRR2 and PRP28. We propose that GTP hydrolysis results in a rearrangement between Prp8 and the C terminus of Snu114 that leads to release of U1 and U4, thus activating the spliceosome for catalysis. P RE-mRNA splicing is catalyzed by the spliceosome, of GTP hydrolysis to drive rearrangements of the spliceosome (Fabrizio et al. 1997). a large dynamic complex composed of five small nuclear RNAs (snRNAs) and Ͼ80 proteins (Burge et Snu114 is packaged with other proteins and the U5 snRNA to form the U5 small ribonucleoprotein particle al. 1998; Jurica and Moore 2003). The chemistry of (snRNP). Prior to formation of the spliceosome, U5 splicing comprises two sequential transesterification resnRNP interacts with the U4/U6 di-snRNP, in which actions (Moore et al. 1993). In the first reaction, the 5Ј U4 and U6 snRNAs are extensively base paired, thus splice site is cleaved and a branched lariat structure is forming U4/U6·U5 tri-snRNP (reviewed in Burge et al. formed within the intron. In the second reaction, the 1998). According to the canonical model of spliceosome 3Ј splice site is cleaved and the two exons are joined assembly, the tri-snRNP is then recruited to the pretogether. During the splicing cycle, the RNA and prospliceosome, in which U1 snRNA is base paired with tein components of the spliceosome undergo numerous the 5Ј splice site and U2 snRNA is base paired with the rearrangements, which must be highly coordinated to branchpoint sequence, an intronic consensus sequence ensure fidelity of the process (Staley and Guthrie near the 3Ј splice site. Although the addition of tri-1998). Most of these rearrangements appear to be ensnRNP forms the complete spliceosome, this complex ergy dependent and are correlated with the activity of is catalytically inert. Activation requires that the U1/5Ј individual ATPases of the DExD/H-box family. Eight splice site interaction and the base pairing between U4 known DExD/H-box proteins are required for the splicand U6 be disrupted, such that U1 and U4 are no longer ing cycle, and mutations in these proteins inhibit the stably associated with the spliceosome. In contrast to ATP-dependent steps of splicing (Staley and Guthrie the stepwise pathway of spliceosome assembly,
P RE-mRNA splicing is catalyzed by the spliceosome, of GTP hydrolysis to drive rearrangements of the spliceosome (Fabrizio et al. 1997) . a large dynamic complex composed of five small nuclear RNAs (snRNAs) and Ͼ80 proteins (Burge et Snu114 is packaged with other proteins and the U5 snRNA to form the U5 small ribonucleoprotein particle al. Jurica and Moore 2003) . The chemistry of (snRNP). Prior to formation of the spliceosome, U5 splicing comprises two sequential transesterification resnRNP interacts with the U4/U6 di-snRNP, in which actions (Moore et al. 1993) . In the first reaction, the 5Ј U4 and U6 snRNAs are extensively base paired, thus splice site is cleaved and a branched lariat structure is forming U4/U6·U5 tri-snRNP (reviewed in Burge et al. formed within the intron. In the second reaction, the 1998). According to the canonical model of spliceosome 3Ј splice site is cleaved and the two exons are joined assembly, the tri-snRNP is then recruited to the pretogether. During the splicing cycle, the RNA and prospliceosome, in which U1 snRNA is base paired with tein components of the spliceosome undergo numerous the 5Ј splice site and U2 snRNA is base paired with the rearrangements, which must be highly coordinated to branchpoint sequence, an intronic consensus sequence ensure fidelity of the process (Staley and Guthrie near the 3Ј splice site. Although the addition of tri -1998) . Most of these rearrangements appear to be ensnRNP forms the complete spliceosome, this complex ergy dependent and are correlated with the activity of is catalytically inert. Activation requires that the U1/5Ј individual ATPases of the DExD/H-box family. Eight splice site interaction and the base pairing between U4 known DExD/H-box proteins are required for the splicand U6 be disrupted, such that U1 and U4 are no longer ing cycle, and mutations in these proteins inhibit the stably associated with the spliceosome. In contrast to ATP-dependent steps of splicing (Staley and Guthrie the stepwise pathway of spliceosome assembly, recent 1998). Additionally, splicing requires one GTPase, evidence suggests that a holospliceosome containing all Snu114, which is an essential protein in Saccharomyces five snRNPs interacts as a complex with each intron cerevisiae (Fabrizio et al. 1997) . Notably, Snu114 is ho- (Stevens et al. 2002) . Nonetheless, ordered rearrangemologous to the ribosomal translocase elongation factor ments of the snRNPs must occur prior to catalysis. G (EF-G in prokaryotes/EF2 in eukaryotes), leading to
Rearrangements that occur during the early stages of the hypothesis that Snu114 may similarly use the energy spliceosome activation are regulated by several components of the U5 snRNP (Brow 2002) . The Prp28 ATPase is required to unwind the U1/5Ј splice site duplex, possi- 1 TABLE 1 and the Brr2 ATPase is required to unwind the U4/U6 duplex (Laggerbauer et al. 1998; Raghunathan and Yeast strains used in this study Guthrie 1998a; Kim and Rossi 1999) . Presumably, the activities of Prp28 and Brr2 must be tightly regulated and Brr2 until spliceosome formation has occurred pPR151 (Kuhn et al. 2002) . The mechanism by which Prp8 inhib- actions between the snu114 alleles and mutations in factors involved in snRNP formation and spliceosome activation. In particular, synthetically lethal interactions AL) (Giaever et al. 2002) . A PRP8 deletion strain was created by transforming a wild-type diploid with the PRP8::LYS2 SacI/
with snu114-60 demonstrate a critical function for the C ApaI fragment from pJU224 (Umen and Guthrie 1996) ; integterminus of the protein during spliceosome activation.
rants were confirmed by PCR. sad1-1 (BSY387) (Lygerou et al. 1999) , prp2-1 (SS304), and prp19-1 (ts87) (Vijayraghavan et al. 1989 ) strains were backcrossed twice to snu114::KanMX MATERIALS AND METHODS strains; prp5-1 (SPJ 5.41) (Vijayraghavan et al. 1989) was crossed once to a snu114::KanMX strain. yTB136 was derived Strains and plasmids: Yeast strains are listed in Table 1 and  plasmids are listed in Table 2 . All strains are isogenic with from GLS618 (Rader and Guthrie 2002), and yTV161 was derived from yS79 (MAT␣ sister of yS78; Wang and Guthrie BY4743 (Giaever et al. 2002) , which is an S288C derivative, unless otherwise noted. Heterozygous diploids with KanMX 1998) . yTB2 was created by sporulating YPF5 (Fabrizio et al. 1997 et al. (2002) pRS plasmids are described by Sikorski and Hieter (1989) and pSE plasmids are described by Elledge and Davis (1988) . fying pTB1 (pRS316/SNU114) (Fabrizio et al. 1997) with the codon of SNU114 by inserting the annealed oligos oKD140 (5Ј-AATTCCCAGAACAAAAATTGATTTCTGAAGAAGATTT primer pairs oTB1 (5Ј-GGGAACAAAAGCTGGGTACCGGGC-3Ј)/oTB2 (5Ј-GGAAGCGAATTCCATTTTGCTATGTTAGGA GAATA-3Ј) and oKD141 (5Ј-GATCTATTCAAATCTTCTTCA GAAATCAATTTTTGTTCTGGG-3Ј), which have overhanging GCTATTG-3Ј) and oTB3 (5Ј-CCGACCGAATTCAGATCTG AAGGTGACGATTTATTCGATGA-3Ј)/oTB4 (5Ј-ATCCTCT EcoRI/Bgl II sites, into the same sites of pTB4. The resulting plasmid was named pTB19. pTB19 was transformed into yTB2, CCGGAATGTTAGCCAT-3Ј). The oTB1/oTB2 PCR product was digested with KpnI and Eco RI and inserted into the same the plasmid pTB1 was lost by passage on 5-FOA media, and the presence of the myc epitope was confirmed by Western sites of pRS316. The resulting plasmid and the oTB3/oTB4 PCR product were digested with Eco RI and BamHI and ligated blotting with the 9E10 antibody (BAbCO). The yeast strain carrying pTB19 grew at the same rate as the strain with pTB1 together. The 4.73-kb Bsp EI-Nsi I fragment of the resulting plasmid was ligated with the 3.62-kb Bsp EI/Nsi I fragment of at 16Њ, 25Њ, 30Њ, and 37Њ. The snu114-50 mutations E910G and C928R were separated pTB1 to create pTB3. The SNU114-containing Xho I/Sac I fragments of pTB1 and pTB3 were inserted into the same sites in by digesting pRS314/snu114-50 and pTB19 with Pst I and Nde I and inserting the 356-bp fragment from each plasmid into pRS314 to create pTB2 and pTB4, respectively.
A single myc epitope was placed immediately after the start the 7.89-kb fragment of the other plasmid.
To remove the myc tag and/or the restriction sites from pTB132 were linearized with Nhe I (pTB126) or Eco47III (pTB130/132), transformed into yTB128, and selected on SDthe N terminus of snu114 alleles, the following restriction enzymes were used to clone the snu114 mutations into pTB2:
URA media at 25Њ. Following growth on 5-FOA, transformants were streaked to YPD and grown at 16Њ, 25Њ, and 37Њ to select Bsp , , , and for thermal-sensitive (ts) or ts/cold-sensitive (cs) integrants. Primer extensions: For primer extensions, the following Pst I and Sac I (snu114-60). Plasmids pRS314/ were named strains were grown in liquid YPD media to OD 0.5-1.0: yTB128 (SNU114), yTB165 (snu114-60), and yTB171 (snu114-12), all pTB95-102. The snu114 alleles were moved from pRS314 (pTB95-102) to pRS315 (pTB106-113) by transforming the grown at 25Њ; and yTB23 carrying either pTB106 (SNU114) or pTB111 (snu114-40), grown at 30Њ. Cells were spun down, PCR-amplified LEU2 marker from pRS315 with HindIII-cut pRS314/snu114 plasmids into a wild-type strain. Plasmids were resuspended in YPD media preincubated at 37Њ or 16Њ, and grown in water baths at either 37Њ or 16Њ; 10-ml aliquots were recovered from LEU2ϩ transformants.
Mutagenesis of SNU114 : SNU114 was PCR amplified in two removed at the indicated times. Cultures were diluted during the time course to maintain an OD between 0.5 and 1.0. prp16-2 fragments. Fragment 1 was amplified with oTB7 (5Ј-CTTGCC AACGGCTGACGATTGC-3Ј; 67 bp upstream of start AUG)
[yS79 (Wang and Guthrie 1998) ϩ BHM110] was shifted to 37Њ for 3 hr as a control for a mutant that blocks the second and oTB8 (5Ј-CAAACAGTCCATATACAGCTCTCC-3Ј; 1965 bp downstream of start AUG). Fragment 2 was amplified with step of splicing. RNA was isolated (Schmitt et al. 1990) , and primer extension was performed as described (Boorstein oTB9 (5Ј-CCGCGACGTTGTACTCTGTAAAG-3Ј; 1720 bp downstream of start AUG) and oTB10 (5Ј-CCAGTGAATTG and Craig 1989). Ten micrograms of RNA was used per reaction. The following oligos were used: U3, 5Ј-CCAAGTTGG TAATACGACTCAC-3Ј; 3270 bp downstream of start AUG). Mutagenesis was performed under standard PCR conditions, ATTCAGTGGCTC-3Ј; RPS17/RP51, 5Ј-CTTAGAAGCACGC TTGACGG-3Ј; PGK1, 5Ј-ATCTTGGGTGGTGTTCC-3Ј; and using the natural error rate of Taq DNA polymerase. PCR reactions (100 l volume) contained 1ϫ Taq buffer (Roche), U14, 5Ј-ACGATGGGTTCGTAAGCGTACTCCTACCGT-3Ј. Data were quantitated by phosphorimager analysis (Molecular 200 m each dNTP, 400 nm each oligo, 2.5 units of Taq (Roche), and 10 ng plasmid DNA. The PCR cycling parameters Dynamics, Sunnyvale, CA). In vitro splicing assays: Liquid cultures of yTB23 in which were the following: 2 min at 94Њ; 10 cycles of 1 min at 94Њ, 1 min at 55Њ, 2 min at 72Њ; and 4 min at 72Њ. After every 10 pTB1 had been replaced by pTB106 (SNU114), pTB107 (snu114-12), pTB111 (snu114-40), or pTB113 (snu114-60) cycles of PCR amplification, reactions were diluted 1:100. Two separate sets of reactions were performed (set A/B and set were grown at 30Њ to OD 1.2-1.4. Splicing extracts were prepared and actin pre-mRNA was spliced as described (Umen C). For set A, a total of 20 PCR cycles were performed, and an additional 10 cycles gave set B. For set C, a total of 40 and Guthrie 1995). Extracts were preincubated for 20 min at 37Њ or on ice in the presence of splicing buffer components cycles using Taq were performed, followed by an additional 10 cycles using Expand Taq. At least two independent PCR (2.5 mm MgCl2, 60 mm potassium phosphate pH 7, 3% PEG 8000) prior to addition of radiolabeled actin and ATP (final reactions were performed for each set. pTB19 (pRS314/myc-SNU114) was the template for sets A and B and pTB4 (pRS314/ concentrations of 0.5 nm and 2 mm, respectively). Splicing reactions were performed at 25Њ. SNU114) was the template for set C. Fragment 1 PCR products were transformed with the EcoRI/Bst BI-cut vector of pTB19
Testing genetic interactions: To test genetic interactions, we created strains deleted for SNU114 (snu114::KanMX) in or pTB4, and fragment 2 PCR products were transformed with the Bst BI/Nde I-cut vector of pTB19 or pTB4. PCR products combination with deletion or mutation of a second gene. Deletions were covered by wild-type plasmids marked with and gapped vectors were transformed into yTB2. Transformants were selected on SD-TRP media at 25Њ and replica URA3. Plasmids containing mutant alleles of snu114 (and, in some cases, of a second gene) were transformed, and plated to 5-FOA media at 25Њ. Lethality on 5-FOA was 8-13% for fragment 1 and 2-4% for fragment 2, depending on the the ability to lose the URA3-marked wild-type plasmid(s) on 5-FOA was tested. number of PCR cycles. Strains were then tested for conditional lethality by replica plating to YPD and incubating at 16Њ for
The following strains (mutant allele/wild-type allele) were transformed with pTB106-113: yTB102/yTB23 (snu66⌬), yTB-3 days, 25Њ for 1-2 days, and 37Њ for 1 day. Approximately 25,000 colonies were screened for each fragment. Plasmids 103/yTB105 (brr2-1), yTB106/yTB107 (prp28-1), yTB117/yTB-118 (prp5-1), yTB133/yTB23 (brr1D), yTB139/yTB23 (snt309⌬), from strains that were growth impaired at 37Њ or 16Њ were recovered and transformed into yTB2 and yTB13. Plasmids yTB142/yTB143 (sad1-1), yTB144/yTB145 (prp19-1), and yTB146/yTB145 (prp2-1). The strains yTB111/yTB15 (isy1⌬) that conferred conditional growth defects were sequenced by the Biomolecular Resource Center DNA sequencing facility at were transformed with pTB95-102. yTB108 (prp8⌬) was transformed with combinations of either pTB95-102 and pJU204, the University of California, San Francisco. The NCBI BLAST alignment server (http:/ /www.ncbi.nlm.nih.gov/blast/bl2seq/ pAK338, pJU206, and pCC18 or pTB106-113 and pCC11 and pCC121. yTB134 (prp22⌬) was transformed with pTB106-113 wblast2.cgi) was used to identify mutations in the recovered snu114 alleles. and pTB115-117. yTB135 (prp43⌬) was transformed with pTB106-113 and pTB118-121. yTB136 (prp24⌬) was transThe mutations K146I and T147N were created using the QuikChange site-directed mutagenesis method (Stratagene, formed with pTB106-113 and pPR113, pSR53, pSR70, and pSR39. yTB148 (sub2⌬) was transformed with pTB106-113 and La Jolla, CA) with the template pTB2. The mutations P216N and H218R were created using site-directed mutagenesis of pAK354-356. yTV161 (prp16⌬) was transformed with pTB106-113 and pSB58, BHM108-110, and BHM115. Additionally, the template pTB19. Mutations were confirmed by sequencing and were subcloned into fresh plasmids.
snu114⌬N (Bartels et al. 2002) was cloned into pRS315 and transformed into yTB23, yTB102, yTB103, and yTB105-107. Integration of snu114 alleles: An integrating snu114-12 plasmid (pTB126) was made by inserting the 3.3-kb PvuII fragment In all cases, corresponding empty vectors were also transformed as negative controls. Transformants were selected on of pTB107 into the PvuII-cut vector of pRS306. Integrating snu114-40 and snu114-60 plasmids (pTB130 and pTB132) were the appropriate selective media at 25Њ. Between 4 and 14 transformants were streaked onto 5-FOA-containing media created by ligating the 4.25-kb Nhe I/Ngo MIV fragment of pTB126 with the 3.63-kb Nhe I/Ngo MIV fragments of pTB111 and incubated at 25Њ for up to 6 days. If no colonies grew on 5-FOA, the combination of alleles was considered synthetically and pTB113. Integrating plasmids pTB126, pTB130, and lethal. Viable strains were streaked to YPD media at 25Њ. Liquid weak genetic interactions, we cannot distinguish between synthetic enhancement and additive enhancement. cultures of each strain in duplicate were grown overnight at 25Њ and diluted to OD 0.1. Tenfold serial dilutions were grown A high number of transformants of snu114-12, snu114-14, and snu114-15 in combination with prp28-1 or snu66⌬ (and on YPD plates at 16Њ for 8 days and at 25Њ, 30Њ, and 37Њ for up to 4 days. For prp8 strains, six 5-fold serial dilutions were snu114-50 with snu66⌬) either were not viable on 5-FOA or produced very few colonies. For example, for the combination made; the middle three dilutions are shown in Figure 7 . For 
Growth at 37Њ and 16Њ was scored, as compared to wild type (ϩϩϩ). Mutations in the G1 and G3 motifs are listed under the appropriate heading, while remaining mutations are listed as "other."
a Alleles containing a single mutation. b 1A-79 is the allele snu114-14.
of snu114-12 and snu66⌬, 4/14 transformants were not viable was possible because of the high sequence similarity on 5-FOA, and 9/14 transformants produced only a small between the two proteins (26% identity, 46% similarity). 
Growth at 37Њ and 16Њ was scored, as compared to wild type (ϩϩϩ). Mutations found in small clusters in domain III (aa 646-664), domain IVa (aa 842-851), and domain V (aa 909-928) are listed under the appropriate heading, while the remaining mutations are listed as "other." Three alleles with truncations of domain IVb were found: fs, frameshift mutation; ns, nonsense mutation.
a Alleles containing a single mutation. b myc-snu114-60 should be compared to snu114-60 (Table 5) .
plasmid, Ͼ87% of the colonies were viable. We then and are necessary for GTP binding and hydrolysis (Bourne et al. 1991) . Of the 16 alleles from fragment screened for colonies that were unable to grow at 37Њ or 16Њ. From the transformation of mutagenized frag-1 that were sequenced, 6 contain a mutation in the G1 motif, and 4 contain a mutation in the G3 motif. ment 1, we isolated 37 ts strains and one strain that was both cs and ts. Mutagenesis of fragment 2 yielded 54 ts Concomitant with the PCR mutagenesis, we designed two mutations in the G1 motif of SNU114 that are exand three cs/ts strains. Plasmids were recovered from 20 ts strains for each of the fragments and from all of the pected to decrease nucleotide binding (Ogg et al. 1998) ; these mutations, K146I (snu114-15) and T147N, confer cs/ts strains and were retransformed into the starting strain. Five of the plasmids from fragment 1 did not a ts growth phenotype (Table 5) . To study single point mutations in the G3 motif of SNU114 that are predicted retest and were discarded. The remaining plasmids were sequenced.
to affect GTP hydrolysis, we created the individual mutations P216N (snu114-12) and H218R, which had arisen The sequenced alleles contained an average of two mutations per gene, with a range of one to six mutations in combination with other mutations during PCR mutagenesis. Each of these mutations alone causes a ts growth (Tables 3 and 4) . Despite the presence of multiple mutations per allele, many of the mutations clustered within defect (Table 5) . While the structure of the G domain of most GTPases small stretches of highly conserved amino acids, highlighting regions that are important for Snu114 function is similar, an insertion termed the GЈЈ domain is found in EF2 and Snu114, but not in the other translational ( Figure 1A ). Individual amino acids within these clusters were often mutated in multiple independent clones.
GTPases (Aevarsson 1995) . Although no function has been assigned to this domain, it has been postulated to Fragment 1 mutations: Domain I contains the conserved motifs, G1-G5, which are present in all GTPases act as a guanine exchange factor (GEF), since EF2 is Growth was scored at 37Њ and 16Њ, as compared to wild type (ϩϩϩ).
a Site-directed mutation based on Ogg et al. (1998) . b Site-directed mutation based on allele 1C-8 (Table 3 ). Figure 2. -snu114 alleles exhibit conditional growth dec Site-directed mutation based on alleles 1A-6 and 1C-13 fects at 16Њ and 37Њ. (A) Growth of serial dilutions of strains (Table 3) .
carrying wild-type SNU114 and snu114-60, with and without d Separation of mutations in snu114-50 by cloning (Table 4) . the myc epitope. (B) Growth of serial dilutions of snu114 e Removal of myc tag from myc-snu114-60 (Table 4) .
alleles, present as low-copy plasmids with no epitope tag. Cells were spotted onto YPD media and grown at 16Њ for 8 days, 30Њ for 2 days, and 37Њ for 2 days.
not known to have an extrinsic GEF (Aevarsson et al. 1994; Czworkowski et al. 1994) . In Snu114, a single mutation in this domain, L381P (snu114-14), causes sion. Only three sets of mutations were found in this slow growth and a weak ts/cs phenotype.
domain, and all result in early truncation of the protein.
Fragment 2 mutations: Over half of the mutations
The weak ts allele snu114-62 causes a deletion of 23 identified in domains III-V are found within three 10-amino acids, while the ts/cs alleles snu114-60 and to 20-amino-acid stretches, which are underlined in Figsnu114 -61 result in the deletion of 70 and 68 amino ure 1A and highlighted in Figure 1 , C and D. The 23 acids, respectively (Table 4) . sequenced fragment 2 alleles contain a total of 49 muta-
The severity of the growth defect of the C-terminal tions. Thirteen of the mutations fall within a short deletions was affected by the presence of a myc epitope stretch of domain III (residues 645-664), 8 mutations that had been placed at the N terminus of the gene prior are within a small region of domain IVa (residues 842-to mutagenesis. Although myc-snu114-60 and snu114-61 851), and 7 mutations are clustered in domain V (resihave similar deletions, the growth defect of myc-snu114-60 dues 909-928). While a majority of the alleles that arose is much stronger. The allele snu114-61 also contains from mutagenesis of fragment 2 contain multiple mutamutations in domains II and IV and does not contain tions, 6 alleles contain a single point mutation. Four of the myc epitope, perhaps due to homologous recombithese mutations, including snu114-30, are in the domain nation with chromosomal SNU114. We tested whether III cluster, and one, snu114-40, is in the domain IVa any of these differences could suppress the growth decluster. That single-amino-acid changes cause a condifect of myc-snu114-60 and found that removing the myc tional growth defect emphasizes the functional signifiepitope from this allele greatly reduces the severity of cance of these regions. Furthermore, in comparing the growth defect at both high and low temperatures Snu114, EF2, and EF-G, the amino acid cluster in do- (Figure 2A) . The presence or absence of the myc epimain III contains the most conserved stretch of amino tope did not affect the growth phenotype of the other acids outside of domain I (Cammarano et al. 1992) . As snu114 alleles that were further characterized. shown in Figure 1 , C and D, the clusters in domain III Where possible, we focused subsequent experiments on and V are in close proximity to each other and to the a set of alleles with single mutations in each of the domains G3 motif. The cluster of residues in domain IVa forms that were identified above as important. For the work a helix that faces domain IVb.
described below, we used the alleles snu114-15 (G1 motif), In addition to the mutations in domains III, IVa, and snu114-12 (G3 motif), snu114-14 (GЈЈ domain), snu114-V, an additional class of mutations was found in domain 30 (domain III), snu114-40 (domain IVa), snu114-50 IVb. Domain IVb is larger in Snu114 than in its homo-[domain V; snu114-50 contains two mutations, because logs: the domain is 76 residues in Snu114, but only 44 the single mutations did not cause a growth phenotype residues in yeast EF2 and 20 residues in E. coli EF-G (Table 5) ], and snu114-60 (truncation of domain IVb; see ( Figure 1E ). In comparison with EF2, Snu114 domain Tables 3 and 4 ). All alleles are ts. snu114-14 and snu114-60 are only weakly ts as well as weakly cs ( Figure 2B ).
IVb has several insertions as well as a C-terminal exten-Genetic Analysis of Snu114
Figure 3.-snu114 mutations block the first step of splicing in vivo. (A-C) Primer extensions of U3 RNA from wild-type, snu114-12 (A), and snu114-60 (B and C) cells shifted to either 37Њ (A and B) or 16Њ (C). The positions of pre-U3A, pre-U3B, and mature U3 are indicated. The snoRNA U14 was used as a loading control. The top portions of the gels are shown at a darker exposure than the bottom portions. (D) Primer extension of RPS17/RP51 RNA from wild-type and snu114-40 cells shifted to 37Њ. RNA from prp16-2 cells shifted to 37Њ for 3 hr was included in the right lane as a standard for a second-step mutant that causes an increase in the level of lariat intermediate. The two RPS17 mRNA species arise because the oligo hybridizes to both the RPS17A and RPS17B transcripts. PGK1 was used as a loading control. The positions of the unspliced premRNA, lariat intermediate, and spliced mRNA are shown schematically. P/M is the ratio of pre-mRNA to mature RNA. In A-C, pre-U3B was used for P. In D, the two mRNA species were summed for M. For A-D, ratios were normalized such that P/M for wild type at time 0 ϭ 1.0.
snu114 mutants exhibit in vivo and in vitro splicing
intermediate accumulation show that the snu114 mutants block splicing at or before the first chemical step. defects: We tested whether a subset of the snu114 mutations inhibit splicing. To monitor in vivo splicing, we
The data from in vitro splicing in extracts made from snu114 mutant strains grown at the permissive temperapurified RNA from cells that had been shifted to the nonpermissive temperature for various times and perture were consistent with the in vivo splicing data. To monitor splicing in vitro, radiolabeled actin pre-mRNA formed primer extensions on the intron-containing transcripts U3 and RPS17/RP51. U3 is a nucleolar snowas incubated with extracts that had been preincubated either at 37Њ or on ice. The splicing intermediates and RNA, and RPS17 encodes a ribosomal protein. Mutations that block the first chemical step of splicing are products were then separated by PAGE and visualized by phosphorimaging. The snu114-12 extract splices poorly expected to increase the level of precursor mRNA, while mutations that affect the second step of splicing should even at 25Њ, consistent with a constitutive defect ( Figure  4A ). Splicing in both snu114-40 and snu114-60 extracts cause an accumulation of lariat intermediate. Strains containing the integrated snu114-12 allele grow slowly can be inactivated by preincubation at high temperature ( Figure 4 , B and C). While the kinetics of splicing in even at 25Њ and show a constitutive accumulation of U3 precursor ( Figure 3A) . The level of pre-U3 in snu114-snu114-60 extract at 16Њ in vitro are slow, they are not strongly inhibited (data not shown). For all snu114 al-60 cells, which are both ts and cs, increases following a shift to either 37Њ or 16Њ (Figure 3 , B and C). Primer leles, the levels of all splicing intermediates are decreased in the mutant extracts, indicating an early block extension of the less stable RPS17 transcript reveals that shifting snu114-40 to 37Њ causes a rapid increase in preto splicing. Genetic interactions of snu114 mutants: Inhibition of mRNA, as well as a rapid and dramatic decrease in the level of mature mRNA ( Figure 3D ). While primer the first step of splicing can arise for many reasons, including defects in snRNP levels, defects in U1 or U2 extension with U3 allows only the differentiation of precursor from mature RNA, the lariat intermediate of addition, defects in tri-snRNP addition, and defects in activation of the spliceosome. Synthetic enhancement RPS17 can be resolved. In contrast to the second-step mutant prp16-2 (Burgess and Guthrie 1993), none of has proven to be a powerful tool for elucidating functions of and interactions between factors of large multithe snu114 mutants that we tested accumulate lariat intermediate ( Figure 3D and data not shown). Tocomponent complexes (Guarente 1993; Doye and Hurt 1995) . To gain an understanding of the timing of gether, pre-mRNA accumulation and a lack of lariat Snu114 function(s), we examined genetic interactions summarized in Figure 5 (solid stars and shaded stars, respectively). between the snu114 alleles and mutations or deletions of 16 splicing factors known to be required at different Interactions with ATPases: Each of the eight spliceosomal DExD/H box ATPases acts at a clearly defined stages of splicing ( Figure 5 ). We tested each combination for viability and for conditional growth defects.
and distinct stage of splicing (Staley and Guthrie 1998) . Strikingly, mutations in the ATPases Prp28 and Taking into consideration changes in growth rates at 16Њ, 25Њ, 30Њ, and 37Њ, the overall strength of synthetic Brr2, which are needed for activation of the spliceosome, exhibit strong genetic interactions with snu114 enhancement for each interaction was rated on a scale of 0 to 5, where 0 indicates no interaction and 5 indicates mutations. Although snu114-60 has only a weak conditional growth defect, it is inviable in combination with a synthetically lethal interaction ( Table 6 ). Interactions that were synthetically lethal or synthetically sick are prp28-1, a cs mutation of Prp28 that disrupts the ex-(Umen and Guthrie 1995), many of the alleles have synthetic interactions with prp8 mutations that cause earlier splicing defects ( Figures 6B and 7A ). The mutations prp8-1 and prp8-brr impair the formation of U5 and tri-snRNP (Brown and Beggs 1992; Collins 2001) and exhibit strong genetic interactions with snu114 mutations. Notably, prp8-1 and prp8-brr are synthetically lethal with snu114-40 and snu114-60, indicating that Snu114 domain IV is important for interacting with Prp8 during snRNP formation. Additionally, many of the snu114 mutations are synthetically sick or lethal in combination with prp8-201, an allele that affects spliceosome activation (Kuhn et al. 1999) .
Interactions with factors involved in tri-snRNP addition, snRNP biogenesis, and snRNP recycling: Because tion (Makarova et al. 2001) . In yeast, deletion of SNU66 causes a cs growth defect and inhibits the first step of splicing (Gottschalk et al. 1999; Stevens et al. 2001) , change of U1 for U6 at the 5Ј splice site (Staley and Guthrie 1999) (Figure 6A ). prp28-1 is also synthetically and the ts allele sad1-1 blocks splicing and decreases the formation of U4/U6 di-snRNP (Lygerou et al. 1999) . sick in combination with mutations in domain I (snu114-12, snu114-14, and snu114-15) (data not shown). brr2-1, Deletion of SNU66 is synthetically lethal with snu114-60 and enhances the growth defects of snu114-12, -14, -15, a cs mutation that decreases the U4/U6 unwinding activity of Brr2 (Raghunathan and Guthrie 1998a) , is synand -50 ( Figures 6A and 8 and data not shown). All of the snu114 alleles are synthetically lethal or sick in thetically lethal with snu114-60 at 16Њ and 37Њ ( Figures  6A and 7B) . In contrast to prp28-1, brr2-1 interacts combination with sad1-1. The recycling factor Prp24 assists in the base pairing strongly only with snu114-60, although snu114-14 and snu114-40 enhance the cs growth defect ( Figure 7B and of U4 and U6 snRNAs (Raghunathan and Guthrie 1998b) . It has also been proposed to influence spliceodata not shown).
snu114-60 is not synthetically lethal with any of the some activation, as alleles of prp24 are synthetically lethal with prp28-1 and with U4-cs1, a mutation in U4 that other ATPase mutations that were tested ( Figure 6A and data not shown). The growth defects of the other blocks spliceosome activation (Strauss and Guthrie 1991; Kuhn and Brow 2000) . The ts mutation prp24-snu114 alleles are moderately enhanced by mutations in Sub2, which functions during a U2 snRNP addition RRM3sub, which is believed to disrupt the ability of Prp24 to bind RNA (Vidaver et al. 1999) , enhances the (Kistler and Guthrie 2001; Libri et al. 2001; Zhang and Green 2001) ; in Prp2, which acts immediately begrowth defect of snu114-60. However, none of the other snu114 mutations exhibit genetic interactions with prp24 fore the first chemical step (Kim and Lin 1996); and in Prp22, which helps to disassemble the postcatalytic mutations. Deletion of the nonessential gene BRR1 causes a cs spliceosome (Company et al. 1991) . Mutations in Prp5, Prp16, and Prp43, which are involved in U2 addition, growth defect, affects the processing of newly transcribed snRNAs, and causes a decrease in snRNA and second-step catalysis, and spliceosome recycling, respectively, exhibit no genetic interactions with snu114 alleles snRNP levels (Noble and Guthrie 1996; Inada 2004). The deletion of BRR1 is synthetically lethal with snu114-(Schwer and Guthrie 1991; Ruby et al. 1993; Arenas and Abelson 1997) . Together, the pattern of genetic 60 at 16Њ and 37Њ, and the combination of brr1⌬ with the other snu114 mutations impairs growth at 30Њ (Figinteractions with the spliceosomal ATPases suggests that Snu114, and especially domain IVb, is specifically inure 7C and data not shown).
Interactions with the NTC: Finally, we tested compovolved in spliceosome activation.
Interactions with PRP8 alleles: Distinct mutations of nents of the prp-nineteen complex (NTC), a complex that interacts with the spliceosome immediately prior the core U5 protein Prp8 affect several stages of spliceosome assembly and both steps of splicing. While none to the first step of catalysis (Tarn et al. 1993; Chan et al. 2003) . prp19-1, a ts mutation that blocks the first step of the snu114 mutations have strong genetic interactions with prp8-101, which inhibits the second step of splicing of splicing (Vijayraghavan et al. 1989) , enhances the Synthetic interactions between snu114 alleles and alleles of other splicing factors
The strength of synthetic enhancement, based on changes in growth rate at 16Њ, 25Њ, 30Њ, and 37Њ, was rated on a scale of 0 (no interaction) to 5 (synthetic lethality). Boxes are shaded according to strength of interaction.
growth defects of all of the snu114 alleles. Notably, mational rearrangements in the spliceosome. On the basis of comparison with EF-G, Snu114 can be divided Prp19 is an E3 ubiquitin ligase, and the prp19-1 mutation decreases its enzymatic activity . Deleinto five structural domains (I-V), as well as a nonconserved N-terminal domain. In this study, we screened tions of the nonessential NTC proteins ISY1 and SNT309 (C. H. Chen et al. 1998 Chen et al. , 2001 Dix et al. 1999) do not for conditionally lethal alleles of Snu114. We recovered a large number of mutations within the GTPase domain interact genetically with the snu114 alleles.
and in three small clusters of amino acids in domains III-V. Additionally, we found that snu114-60, which DISCUSSION causes an almost complete deletion of the C-terminal domain IVb, causes a conditional growth defect. DoSnu114 is a GTPase with homology to the ribosomal translocase EF-G, suggesting that it may mediate conformain IVb is larger in Snu114 than in its ribosomal homo- Figure 6 .-Synthetic lethal interactions of snu114-60. The following strains were streaked onto 5-FOA media and grown at 25Њ for 3 days: (A) snu114⌬ strains carrying SNU114 on a URA3-marked plasmid, in combination with either a wild-type or a mutant copy of the indicated gene, which had been transformed with SNU114, snu114-60, or an empty LEU2-marked vector; and (B) a ⌬snu114 ⌬prp8 strain containing SNU114 and PRP8 on URA3-marked plasmids that was transformed with snu114-60 and the indicated prp8 allele or empty vector. B is a composite taken from different plates.
logs, suggesting that this domain may be important for of domain IV with respect to domains I and II (Stark et al. 2000; Jorgensen et al. 2003 ) (see Figure 1 , C and an interaction specific to splicing. snu114-60 is synthetically lethal with mutations in prp8 and in other factors D). This conformational rearrangement of EF-G/EF2 is predicted to drive movement of tRNA within the riboinvolved in activation of the spliceosome. We propose that domain IVb interacts with Prp8 to influence the some . By analogy, GTP hydrolysis by Snu114 may cause rearrangements of the spliceoactivities of the DExD/H box ATPases Prp28 and Brr2 during spliceosome activation.
some. All members of the GTPase superfamily share a simiStructural interpretations: Studies of EF-G and EF2 indicate that GTP hydrolysis causes a substantial movement lar architecture of the G domain and contain conserved Figure 7 .-Genetic interactions of snu114 alleles with prp8 alleles, brr2-1, and brr1⌬. (A) Serial dilutions of snu114⌬ prp8⌬ cells carrying the indicated snu114 and prp8 alleles were grown at 30Њ on YPD for 3 days. prp8-1, prp8-101, and prp8-brr were present on low-copy (CEN) plasmids; prp8-201 was present on a high-copy (2) plasmid. (B) Serial dilutions of snu114⌬ brr2⌬ cells carrying the indicated snu114 alleles and either BRR2 or brr2-1. (C) Serial dilutions of snu114⌬ brr1⌬ cells and snu114⌬ BRR1 cells carrying the indicated SNU114 alleles. In B and C, serial dilutions were grown on YPD for 8 days at 16Њ and for 2 days at 25Њ, 30Њ, and 37Њ.
splicing defect, we predict that domain IVb could be an interaction domain that communicates conformational changes of Snu114 to other splicing factors.
The ␤␣␤␤␣␤ structure of domains III, IVa, and V of EF-G is characteristic of the RNA recognition motif (RRM) (Aevarsson et al. 1994; Murzin 1995; Laurberg et al. 2000) . In RRM domains, hydrophobic residues in two of the ␤-sheets interact directly with RNA (Varani and Nagai 1998). In our mutagenesis of Snu-114, we found very few mutations in residues that would be predicted to interact with RNA; thus, our data do it is possible that we failed to obtain such mutations mutants are shown. Tetrads dissected from the cross of snu114-12 with snu66⌬ were photographed after 8 days of growth at because they cause lethality or because our screen was 25Њ, while the other tetrads are shown at day 4. snu114-60 not saturating.
snu66⌬ spores were not viable even after 8 days.
Biochemistry and genetics suggest that Snu114 functions during spliceosome activation: We have found that mutations in Snu114 block splicing prior to the first motifs (G1-G5) that interact with GTP/GDP (Bourne chemical step both in vivo and in vitro. A first-step block et Sprang 1997) . Our screen for conditionally to splicing could reflect defects at a number of stages, lethal alleles of Snu114 identified mutations in the G1 including snRNP biogenesis and stability, tri-snRNP adand G3 motifs, which are predicted to cause defects in dition to the spliceosome, and spliceosome activation. GTP binding and hydrolysis (Sigal et al. 1986 ; Anborgh
In fact, we found that snu114 mutants exhibit genetic et Zeidler et al. 1995) . In multidomain G prointeractions with splicing mutants that affect each of teins, the GTP/GDP binding status is communicated to these stages ( Figure 5 ). However, snu114 mutants do other domains via rearrangements of the G2 and G3 not interact genetically with any factors that function motifs (Sprang 1997) . The clusters of mutations that after the first step of catalysis, in agreement with the we identified in domains III and V are located near biochemical data showing a first-step block. points of contact with the G3 motif (Figure 1, C and A number of proteins that we tested affect multiple D). Although the G2 motif is disordered in all EF-G/ stages of splicing. For example, Prp24 and Sad1 are EF2 structures, comparison with the structure of the both implicated in tri-snRNP addition/reorganization GTPase elongation factor Tu (EF-Tu) suggests that it is as well as in formation of U4/U6 snRNP (Raghunaalso close to the domain III cluster (Laurberg et al. than and Guthrie 1998b; Lygerou et al. 1999; Kuhn 2000) . Therefore, the mutations that we found in doand Brow 2000; Makarova et al. 2001) . The snRNP mains III and V may impair a conformational rearrangebiogenesis factor BRR1 exhibits genetic interactions not ment of the protein that normally results from GTP only with snRNP biogenesis factors, but also with factors hydrolysis.
that affect spliceosome assembly. Interestingly, brr1⌬ Domain IV of EF-G is necessary for transmitting a and the snu114 alleles are synthetically lethal with many rearrangement within the protein, arising from GTP of the same mutations, including prp24-RRM3sub, sub2 hydrolysis, into a conformational change of the ribomutations, sad1-1, and snu66⌬ (Inada 2004). The gesome, as deletion of IVa or IVa ϩ IVb decreases translonetic interactions observed between snu114 mutations cation by ‫-0002ف‬fold without affecting GTP hydrolysis and prp24-RRM3sub, sad1-1, and brr1⌬ could arise be- (Rodnina et al. 1997; Martemyanov and Gudkov 1999;  cause (a) all of the proteins are involved in the addition Savelsbergh et al. 2000) . Notably, deletion of six amino and rearrangement of tri-snRNP, (b) the function of acids in EF-G that correspond to the cluster of mutant Snu114 during spliceosome activation is particularly amino acids that we identified in Snu114 domain IVa, sensitive to low levels of snRNPs, or (c) Snu114 is also including snu114-40, causes a 300-fold reduction in necessary for snRNP biogenesis. However, snu114-60, translocation of the ribosome (Savelsbergh et al. which has the strongest interactions with prp24, sad1, 2000). Thus, the mutations in Snu114 domain IVa may and brr1 mutants, contains wild-type snRNP levels (T. J. prevent the transmission of a conformational rearrangeBrenner and C. Guthrie, unpublished data). ment that normally results from GTP hydrolysis or nuSnu114 alleles exhibit strong genetic interactions with cleotide exchange. Studies of EF-G/EF2 have not difactors involved in spliceosome activation, including rectly addressed the role of domain IVb alone (although prp28-1, brr2-1, and prp8-201 (Guthrie 1998a ; Kuhn et this domain is only 20 amino acids in E. coli). On the al. 1999; Raghunathan and Staley and Guthrie basis of our finding that deletion of domain IVb 1999) . We also found strong genetic interactions with deletion of SNU66 and mutation of SAD1, factors in-(snu114-60) causes a conditional growth defect and a Figure 9 .-Model for Snu114 activity during spliceosome activation. We propose that Snu114 is bound to GTP when tri-snRNP first interacts with the spliceosome. Proper interaction between tri-snRNP and the spliceosome induces GTP hydrolysis, causing a conformational rearrangement of Snu114. This alters the interaction between domain IV of Snu114 (marked by a star) and Prp8, changing the conformation of Prp8. This triggers the activity of the ATPases Prp28 and Brr2, leading to the release of U1 and U4. 114, Snu114; 8, Prp8; 2, Brr2; 28, Prp28. volved in tri-snRNP addition (Makarova et al. 2001) .
Synthetic lethality between snu114-60 and mutations in factors involved in spliceosome activation indicates All of these genetic interactions may be related, as mutations that block spliceosome activation, including prpa pivotal role for domain IVb in this process. Previous genetic data have suggested that an allosteric interaction 28-1 and brr2-1, decrease the interaction of tri-snRNP with the spliceosome (Raghunathan and Guthrie between Prp8 and the ATPases Prp28 and Brr2 regulates the timing of spliceosome activation (Kuhn and Brow 1998a; Staley and Guthrie 1999) , indicating that rearrangements within the tri-snRNP are necessary for its 2000; Kuhn et al. 2002) . The mutations prp28-1 and brr2-1 are synthetically lethal with the U4-cs1 mutation, stable association with the spliceosome. Together, these genetic interactions strongly implicate Snu114 in spliceowhich increases the base pairing between U4 and U6 snRNAs and inhibits the release of U1 and U4 from the some activation.
The N-and C-terminal domains of Snu114 are involved spliceosome (Li and Brow 1996; Kuhn et al. 1999) . A large number of prp8 alleles, including prp8-201, can in similar functions: Snu114 contains a 120-amino-acid N-terminal domain that is not found in EF-G/EF2. Previsuppress the cold sensitivity of U4-cs1, and a subset of these prp8 alleles can suppress prp28-1 or brr2-1. Thus, ous studies showed that deletion of this domain (snu114⌬N) causes a ts growth defect and a block to the it has been hypothesized that Prp8 inhibits the activity of the ATPases until spliceosome formation has occurred, release of U1 and U4 from the spliceosome (Bartels et al. 2002) . Similar to the biochemical phenotype of while certain mutations of prp8 may relax this inhibition. On the basis of the strong genetic interactions besnu114⌬N, genetic interactions suggest that snu114-60 causes defects in spliceosome activation. Furthermore, tween SNU114 and PRP8, PRP28, and BRR2, we suggest that Snu114 may regulate Prp8's inhibition of Prp28 we found that the presence of a 15-amino -acid epitope tag at the N terminus of Snu114 is synthetically lethal and Brr2 (Figure 9 ). We hypothesize that Snu114 is bound to GTP when tri-snRNP binds to the spliceosome. with snu114-60 at 16Њ and 37Њ (Figure 2A ), which suggests that both the N-terminal domain and domain IVb GTP hydrolysis could be triggered by interactions with U1 snRNP, since Snu114 and the U1 proteins Prp39 are necessary for the same process. If the N and C termini were involved in the same function, we preand Prp40 interact with neighboring regions of Prp8, according to yeast two-hybrid analyses (Abovich and dicted that they would exhibit the same genetic interactions. Similarly to snu114-60, snu114⌬N is synthetically Rosbash 1997; Dix et al. 1998; van Nues and Beggs 2001; Grainger and Beggs 2005) . Thus, successful inlethal with prp28-1 and snu66⌬ and sick with brr2-1 (T. J. Brenner and C. Guthrie, unpublished data). We conteraction with the spliceosome would induce GTP hydrolysis by Snu114 and a concomitant structural reclude that both domains are necessary for tri-snRNP addition/spliceosome activation. It is possible that the arrangement of domains III-V with relation to the N terminus. In particular, this may modify the interaction N-terminal domain is necessary for the activation of GTPase, while the C-terminal domain is necessary to between domain IVb and Prp8, which in turn could alter the conformation of Prp8 and lead to the unwinding of transmit a conformational change driven by GTP hydrolysis. Alternatively, it is possible that both domains must the U1/5Ј splice site duplex by Prp28 and the U4/U6 duplex by Brr2. It is possible that Prp8 sequesters the interact with other factors, such as Prp8, for a conformational change in Snu114 to be transmitted.
RNA helices, and an altered conformation of Prp8 would allow Brr2 and Prp28 access to their substrates. A model for the activity of Snu114: Snu114 and Prp8 physically interact with each other, and both proteins Alternatively, Prp8 could inhibit the ATPase activity of Prp28 and Brr2 via direct physical interactions with the can be crosslinked to U5 snRNA (Achsel et al. 1998; Dix et al. 1998) . Thus, interactions between Snu114, DExD/H-box proteins, and altering the conformation of Prp8 could relieve the inhibition by severing these Prp8, and U5 snRNA form the core of U5 snRNP. Domain IVa/IVb of Snu114 may be particularly important associations (Kuhn and Brow 2000; Kuhn et al. 2002) . Previous biochemical studies support the model that for this interaction, as snu114-40 and snu114-60 are synthetically lethal with prp8-1 and prp8-brr.
Snu114 hydrolyzes GTP during spliceosome activation.
A mutation that is expected to convert the nucleotide strong genetic interactions between sad1-1 and snu114 mutations suggests that deubiquitination of Snu114 is specificity of Snu114 from GTP to XTP causes a temperature-sensitive block to U1 and U4 release, which can essential for splicing. Ubiquitination of Snu114 may also affect its interactions with Prp8, as Prp8 is predicted to be partially overcome by addition of XTP (Bartels et al. 2003) . Nonhydrolyzable XTP did not stimulate snRNA bind ubiquitin via its Jab/MPN domain. We are most interested in determining when during splicing Snu114 release, suggesting that GTP hydrolysis, and not just GTP binding, is important (Bartels et al. 2003) .
is ubiquitinated and how this is affected by mutations in PRP19, SAD1, and PRP8. For most GTPases, GTPase-activating proteins (GAPs) are necessary to stimulate GTP hydrolysis. The ribosome tempting to speculate that interactions between spliceosomal components and Snu114 domain IV, which would correspond to the anticodon arm of tRNA, may be nec-LITERATURE CITED essary to trigger GTPase activity. Just as GTP hydrolysis by EF-Tu functions as a checkpoint to ensure that the
